CoChat

Designing and Interpreting Coronavirus Disease 2019 (COVID-19) Diagnostics: Mathematics, Visual Logistics, and Low Prevalence

Open access
Kost, Gerald J. · 2021 · Archives of Pathology & Laboratory Medicine

The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.

Abstract

Context.—: Coronavirus infectious disease-19 (COVID-19) diagnostics require understanding of how predictive values depend on sensitivity, specificity, and especially, low prevalence. Clear expectations, high sensitivity and specificity, and manufacturer disclosure will facilitate excellence of tests. Objectives.—: To derive mathematical equations for designing and interpreting COVID-19 tests, assess US Food and Drug Administration (FDA) Emergency Use Authorization and Health Canada minimum requirements, establish sensitivity and specificity tiers, and enhance clinical performance in low prevalence settings. Design.—: PubMed and other sources generated articles on COVID-19 testing and prevalence. EndNote X9.1 consolidated references. Mathematica and open access software helped prove equations, perform recursive calculations, graph multivariate relationships, and visualize patterns, including a new relationship, predictive value geometric mean-squared. Results.—: Derived equations were used to illustrate shortcomings of COVID-19 diagnostics in low prevalence. Visual logistics helped establish sensitivity/specificity tiers. FDA/Canada's 90% sensitivity, 95% specificity minimum requirements generate excessive false positives at low prevalence. False positives exceed true positives at prevalence lower than 5.3%, or if sensitivity is improved to 100% and specificity to 98%, at prevalence lower than 2%. Recursive testing improves predictive value. Three tiers emerged from these results. With 100% sensitivity, physicians can select desired predictive values, then input local prevalence, to determine suitable specificity. Conclusions.—: Understanding low prevalence impact will help health care providers meet COVID-19 needs for effective testing. Laypersons should receive clinical performance disclosure when submitting specimens. Home testing needs to meet the same high standards as other tests. In the long run, it will be more cost-effective to improve COVID-19 point-of-care tests rather than repeat testing multiple times.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.5858/arpa.2020-0443-sa

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 35 references

Research works printed but not linked: 13

  1. Calfas J. California mandates masks as cases climb. Wall Street Journal. 2020; 275(143): A7.
  2. Pence M. There isn't a Coronavirus ‘second wave.' Wall Street Journal . 2020; 275(141): A19.
  3. Galston W. Test every American for COVID-19. Wall Street Journal. 2020; 276(30): A15.
  4. Palazzalo J, West MG, Vielkind J, Berger P. New York response worsened the pandemic. Wall Street Journal. 2020; 275(137): A1, A8, A9.
  5. Hua S. New outbreak of virus cases rattles Beijing. Wall Street Journal. 2020; 273(140): A1, A8.
  6. Ansari T. Virus cases hit records in many states. Wall Street Journal. 2020; 275(147): A1, A6.
  7. Abbott B, Marcus AD . Race is on to devise fast at-home tests. Wall Street Journal. 2020; 275(123): A4.
  8. Scott CL . At-home testing arrives with accuracy and access questions. Wall Street Journal. 2020; 275(129): A9.
  9. Krouse S. Small business grapples with Covid testing. Wall Street Journal. 2020; 275(144): B1, B6.
  10. Kost GJ, Zhou Y, Katip P. Understanding point of care culture improves resilience and standards of care in limited-resource countries. In:Kost GJ, ed, Curtis CM, assoc ed. Global Point of Care: Strategies for Disasters, Emergencies, and Public Health Preparedness. Washington, DC: AACC Press-Elsevier;2015: 471– 490.
  11. Magalhaes L, Forero J. Latin America is pandemic's grim new center. Wall Street Journal. 2020; 275(147): A8.
  12. Rashid ZZ, Othman SN, Samat MNA, Ali UK, Wong KK . Diagnostic performance of COVBID-19 serology assays. Malaysian J Pathol. 2020; 42(1): 13– 21.
  13. Kost GJ, Ferguson WJ, Truong A-T, et al. The Ebola Spatial Care PathTM: point-of-care lessons learned for stopping outbreaks. Clin Lab Int. 2015; 39: 6– 14.

Cited by

See all 10

Metadata

Authors
Kost, G. J.
Affiliations
University of California, Davis (US)
Corresponding author
Kost, Gerald J.
Venue
Archives of Pathology & Laboratory Medicine
Published
2020-09-09
Volume
145
Issue
3
Pages
291-307
ISSN
  • 0003-9985 (ISSN-L)
  • 1543-2165
OpenAlex
W3083810684
Cited by
9
References
34
Citations by year
2024: 2 · 2023: 1 · 2022: 1 · 2021: 5
FWCI
0.23
Type
journal article
Language
en
Open access
Licence
public-domain
Locations
  • Archives of Pathology & Laboratory Medicine (publishedVersion, public-domain)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 detection and testing
  • Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods in Epidemiology
  • Physical Sciences › Mathematics › Modeling and Simulation › COVID-19 epidemiological studies
Keywords
COVID-19 diagnosis, diagnostic test sensitivity and specificity, low prevalence, predictive value, false positives, FDA emergency use authorization, point-of-care testing, home testing
MeSH terms
COVID-19, SARS-CoV-2, COVID-19 Testing, Algorithms, Humans, Models, Theoretical, Research Design, Sensitivity and Specificity, Reproducibility of Results, Prevalence, Epidemics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Designing and Interpreting Coronavirus Disease 2019 (COVID-19) Diagnostics: Mathematics, Visual Logistics, and Low Prevalence. https://app.cochat.ai/papers/10.5858/arpa.2020-0443-sa
The paper
Kost, G. J. (2021). Designing and Interpreting Coronavirus Disease 2019 (COVID-19) Diagnostics: Mathematics, Visual Logistics, and Low Prevalence. Archives of Pathology & Laboratory Medicine. https://doi.org/10.5858/arpa.2020-0443-sa

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.